If that cost of capital is 5 percent (as I said, everything is debatable), then the up-front capital cost is $2.5 million a mile per year, or $600 million for a 240-mile line. The other cost that is independent of the number of riders is track maintenance.One recent European estimate puts that cost at $140,000 a mile per year for a two-track system. A feasibility study of high-speed rail in Britain came up with the considerably higher figure of $493,000 a mile for surface trains.Iâll stay closer to the lower estimate and go with $200,000 a mile per year, which brings the fixed costs of the track up to $648 million per annum.f that cost of capital is 5 percent (as I said, everything is debatable), then the up-front capital cost is $2.5 million a mile per year, or $600 million for a 240-mile line. The other cost that is independent of the number of riders is track maintenance.
Staph: Mrsa stands for methicillin resistant staphylococcus aureus. This is the name of a specific type of staph bacteria that is not curable / treatable by methicillin (a penicillin like drug). In most instances penicillin and cephalosporin type antibiotics will not kill mrsa.et help from a doctor now âº. MRSA: Mrsa is the abbreviation for methicillin resistant staph aureus. It is an infection with a bacteria that has figured out how to avoid being killed by usually effective antibiotics. Most mrsa, if you have a healthy immune system is curable.
HA-MRSA is resistant even to these antibiotics and often is susceptible only to vancomycin. Newer drugs, such as linezolid (belonging to the newer oxazolidinones class) and daptomycin, are effective against both CA-MRSA and HA-MRSA.